Amgen’s fair value target has seen a modest increase, now set at $318.51 compared to its previous level of $311.88. Recent ...
Artificial intelligence (AI) is set to transform the care of women with cancer. From early detection via digital phenotyping ...
Phase 3 data to be presented at ACAAI demonstrate Dupixent significantly reduced key nasal signs and symptoms including sinus opacification, nasal congestion and nasal polyps in patients aged 6 years ...
Tezspire is the first biologic approved for CRSwNP targeting TSLP, expanding its respiratory indications. The drug acts on airway epithelium, inhibiting TSLP, an early-stage inflammatory cytokine. The ...
If nasal polyps are interfering with your sleep, here’s how you can reduce symptoms and clear your nasal passages to rest better at night. And without proper treatment, the number of people losing ...
You may finally have an answer to what’s been causing all that congestion. But you probably still have lingering questions about this chronic nasal condition. Even after you’ve spoken to your doctor, ...
SAN DIEGO -- Tezepelumab (Tezspire) reduced nasal polyps and symptoms in severe chronic rhinosinusitis while also decreasing need for further treatments, the WAYPOINT trial showed. The monoclonal ...
Treatment with tezepelumab has been effective for sinonasal symptoms in patients with severe, uncontrolled asthma and a history of chronic rhinosinusitis with nasal polyps, but its efficacy and safety ...
This important study advances our understanding of early Cambrian cnidarian paleoecology and suggests that the reconstructed ancestral feeding and respiration mechanisms predate jet-propelled swimming ...
Wendy Wisner is a journalist and international board certified lactation consultant (IBCLC). She has written about all things pregnancy, maternal/child health, parenting, and general health and ...
Please provide your email address to receive an email when new articles are posted on . The frequency of polyp diagnoses in close relatives was strongly associated with colorectal cancer risk. Polyp ...